• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚磷酸雌二醇的临床药理学

Clinical pharmacology of polyestradiol phosphate.

作者信息

Gunnarsson P O, Norlén B J

机构信息

Department of Pharmacokinetics, Pharmacia LEO Therapeutics AB, Helsingborg, Sweden.

出版信息

Prostate. 1988;13(4):299-304. doi: 10.1002/pros.2990130405.

DOI:10.1002/pros.2990130405
PMID:3217277
Abstract

The results of the present studies demonstrate that intramuscular injections of polyestradiol phosphate (PEP) produce not only considerably increased estrogen concentration in plasma but also maintain the same estrone/estradiol ratio as in normal men. Monthly injections of PEP produce persistent elevation of the plasma estradiol levels throughout the dose interval, and rising PEP doses produce proportionately increasing steady-state plasma concentrations of estradiol. The steady-state plasma concentrations of testosterone are reduced to 45, 25, and 15% of the pretreatment concentrations after treatment every fourth week with 80, 160, and 240 mg PEP, respectively.

摘要

本研究结果表明,肌肉注射磷酸聚雌二醇(PEP)不仅可使血浆中雌激素浓度显著升高,而且能维持与正常男性相同的雌酮/雌二醇比例。每月注射PEP可使整个剂量间隔内血浆雌二醇水平持续升高,且随着PEP剂量增加,血浆雌二醇稳态浓度也相应升高。分别每四周用80、160和240mg PEP治疗后,睾酮的稳态血浆浓度分别降至治疗前浓度的45%、25%和15%。

相似文献

1
Clinical pharmacology of polyestradiol phosphate.聚磷酸雌二醇的临床药理学
Prostate. 1988;13(4):299-304. doi: 10.1002/pros.2990130405.
2
Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients.前列腺癌患者单次注射聚磷酸雌二醇(Estradurin)的药代动力学及睾酮抑制作用
Prostate. 1996 May;28(5):307-10. doi: 10.1002/(SICI)1097-0045(199605)28:5<307::AID-PROS6>3.0.CO;2-8.
3
Plasma concentrations of estradiol and testosterone in single-drug polyestradiol phosphate therapy for prostatic cancer.前列腺癌单药聚磷酸雌二醇治疗中雌二醇和睾酮的血浆浓度
Eur Urol. 1987;13(3):193-7. doi: 10.1159/000472772.
4
Pharmacodynamic model of testosterone suppression after intramuscular depot estrogen therapy in prostate cancer.前列腺癌肌肉注射长效雌激素治疗后睾酮抑制的药效学模型
Prostate. 2000 Jun 15;44(1):26-30. doi: 10.1002/1097-0045(20000615)44:1<26::aid-pros4>3.0.co;2-p.
5
Single drug polyestradiol phosphate therapy in prostatic cancer.单药聚磷酸雌二醇治疗前列腺癌
Am J Clin Oncol. 1988;11 Suppl 2:S101-3.
6
Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
J Clin Endocrinol Metab. 1996 Jul;81(7):2633-7. doi: 10.1210/jcem.81.7.8675589.
7
Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteral estrogen regimen.雌激素用于晚期前列腺癌治疗的复兴时机?一种胃肠外雌激素治疗方案的药代动力学、内分泌及临床效果
Prostate. 1999 Jul 1;40(2):76-82. doi: 10.1002/(sici)1097-0045(19990701)40:2<76::aid-pros2>3.0.co;2-q.
8
Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate.对前列腺转移性癌患者接受胃肠外雌激素治疗或完全雄激素消融治疗期间潮热情况的前瞻性评估。
J Urol. 2001 Aug;166(2):517-20.
9
Effects of orchidectomy and different modes of high dose estrogen treatment on circulating "free" and total 1,25-dihydroxyvitamin D in patients with prostatic cancer.睾丸切除术及不同方式大剂量雌激素治疗对前列腺癌患者循环中“游离”及总1,25 - 二羟维生素D的影响。
J Steroid Biochem Mol Biol. 1991 Aug;39(2):155-9. doi: 10.1016/0960-0760(91)90056-b.
10
Effects of orchiectomy and polyestradiol phosphate therapy on serum lipoprotein lipids and glucose tolerance in prostatic cancer patients.睾丸切除术和聚磷酸雌二醇治疗对前列腺癌患者血清脂蛋白脂质及葡萄糖耐量的影响。
Eur Urol. 1990;17(3):229-35. doi: 10.1159/000464045.

引用本文的文献

1
Biological Activity and Structural Diversity of Steroids Containing Aromatic Rings, Phosphate Groups, or Halogen Atoms.含芳环、磷酸基团或卤素原子的甾体的生物活性和结构多样性。
Molecules. 2023 Jul 20;28(14):5549. doi: 10.3390/molecules28145549.
2
In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism.计算机预测甾体和三萜类化合物作为潜在的脂代谢调节剂。
Mar Drugs. 2021 Nov 22;19(11):650. doi: 10.3390/md19110650.
3
Vastly extended drug release from poly(pro-17β-estradiol) materials facilitates in vitro neurotrophism and neuroprotection.
聚(原 17β-雌二醇)材料的药物释放大大延长,有助于体外神经营养和神经保护。
Nat Commun. 2019 Oct 23;10(1):4830. doi: 10.1038/s41467-019-12835-w.